Analysis of complement C4 loci in Caucasoids and Japanese with idiopathic membranous nephropathy  by Sacks, Steven H. et al.
Kidney International, Vol. 42 (1992), pp. 882—887
Analysis of complement C4 loci in Caucasoids and Japanese
with idiopathic membranous nephropathy
STEVEN H. SACKS, SHINSUKE NOMURA, CATHERINE WARNER, SETSUYA NAIT0,
SATORU OGAHARA, ROBERT VAUGHAN, and DAVID BRIGGS
Renal and Tissue Typing Laboratories, United Medical and Dental Schools, Guy's Hospital, London, England, United Kingdom and Second
Department of Internal Medicine, School of Medicine, Fukuoka University, Fukuoka, Japan
Analysis of complement C4 loci in Caucasoids and Japanese with
idiopathic membranous nephropathy. Deletion of the HLA class III
complement gene, C4A, has been linked with susceptibility to a number
of autoimmune diseases. In this study, we show a strong positive
association between C4A gene deletion and development of idiopathic
membranous nephropathy (IMN) in European Caucasoids [patients,
17/27 (63%); healthy controls, 13/65 (20%); RR 6.8; P = 0.003]. To
clarify whether C4A deletion is an independent risk factor for IMN or
is increased secondarily to the Caucasoid HLA Al, B8, DR3 extended
haplotype, we examined the frequency of C4A deletion in Japanese
patients, in whom the disease is associated with another HLA haplo-
type (DR2-DQw1). Analysis of 31 Japanese patients and 46 healthy
controls showed that C4A deletion was present in only one patient (3%)
and one control (2%). In addition, examination of the C4B locus in
Japanese patients showed that there was no significant increase in the
estimated frequency of C4B deletion in patients against controls (31 vs.
27%) and no difference in the frequency of the C4B long gene (73 vs.
87%) or C4B short gene (77 vs. 78%). We conclude that although C4A
deletion confers significant risk of IMN in Caucasoids, there is no
significant association between C4 polymorphism, as detected here, and
risk of IMN in Japanese. This suggests that either C4A deletion is
irrelevant to the pathogenesis of IMN or that more than one genetic
mechanism is involved.
Idiopathic membranous nephropathy (IMN) is the most com-
mon cause of primary nephrotic syndrome in adults. It leads to
end-stage renal failure in about half of those affected in Europe
and North America [1]. In Japan, the frequency of end stage
renal disease due to IMN is reported to be much less [1].
Genetic susceptibility to IMN is associated, in northern Euro-
peans, with the extended HLA haplotype, HLA-Al, B8, DR3
[2—8], while in Japan there is a strong association with the
HLA-DR2-DQwI haplotype [9—12]. In North America, no
consistent association with the HLA class II region has been
found [1, 3].
The extended caucasoid Al, B8, DR3 haplotype includes a
set of alleles encoded by the class I, class II and class III
regions of the HLA complex F 13—17]. These include the HLA
class III complement alleles, BP'S, C2*C, C4B*1, and the
non-expressed (or null) C4A allele, C4A*Q0. It is unclear, due
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to strong linkage disequilibrium between the allelic polymor-
phisms the Al, B8, DR3 haplotype represents, whether the
association with IMN derives from the HLA class II region, or
from immune dysfunction related to HLA class III. In systemic
lupus erythematosus, for example, C4A null seems to have a
primary influence on the development of SLE, and in Cauca-
soids is linked to the extended Al, B8, DR3 haplotype [18, 19].
SLE is also a notable cause of secondary membranous nephrop-
athy [1J.
Analysis of the C4 loci by restriction fragment length poly-
morphism has revealed that about 50% of all C4A null alleles in
Caucasoids are due to deletion of the C4A locus [20—22]. This
deletion is about 30 kilobases long and extends to the adjacent
21 hydroxylase gene [20—22]. C4A deletion in Caucasoids
almost invariably occurs with the Al, B8, DR3 haplotype [20],
and C4A is therefore one of a number of genes which could play
a role in the genesis of IMN. In addition, it has recently been
disclosed, by analysis of C4 genotypes in Black Americans, that
C4A deletion may also occur with DR2, conferring increased
risk of SLE [181. We argued that since DR2 and DR3 are the
main IMN disease-susceptibility alleles in Japanese and Cauca-
soids, a primary association with C4A deletion might explain
this link.
In the present study, we carried out molecular analysis of the
C4A locus in Caucasoid and Japanese patients, and healthy
controls. Our first aim was to examine C4A deletion as a risk
marker for IMN in Caucasoids. Secondly, we set out to
examine if there was an independent association between C4A
deletion and IMN in a population for whom IMN is associated
with a non-DR3 haplotype.
Furthermore, analysis of the C4B locus—which is closely
homologous with the C4A locus [23]—has shown that the C4B
gene can be present in a long (22 kb) or short form (16 kb) [20,
21]. An increased frequency of C4B short has been found in
patients with certain autoimmune disease [19]. We therefore
also investigated polymorphism at the C4B locus to see if we
could identify other risk markers associated with IMN in
Japanese.
Methods
Patients
We studied 25 Caucasoid patients referred to Guy's Hospital
Renal Unit and 65 healthy volunteers drawn from the same
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Fig. 1. Schematic representation of the
human C4 and 21-hydroxylase loci on the
short arm of chromosome 6, showing Taq I
restriction fragments hybridizing with the C4
probe, pAT-A. pAT-A reveals a 7.0 kb
fragment with an intact C4A gene, a 6.0 kb
fragment with a "long" C4B gene and a 5.4
kb fragment with a "short" C4B gene. In the
presence of a large (30 kb) C4A/2IOHA
deletion a novel 6.4 kb fragment is revealed.
geographical area. Thirty-one Japanese patients attending
Fukuoka University Hospital and 46 unrelated healthy Japa-
nese controls from the same area were also studied. All patients
had biopsy proven IMN and had no evidence of systemic
disease or exposure to nephrotoxic drugs. In particular, sero-
logical investigations for systemic lupus erythematosus and
chronic infection with hepatitis B were negative.
Cell lines
EBV B-lymphoblastoid cell lines were prepared from periph-
eral blood cells by established methods. B-cell lines from
consanguineously HLA homozygous donors were used to pro-
vide information on C4 Taq 1 RFLP patterns. The HLA
haplotypes of these donors were: WT49: HLA-B17, DR3; AVL:
HLA-A1, B8, DR3, DQw2, Bf*S, C2*C, C4A*Q0, C4B*l;
QBL: HLA-Bl8, DR3, DQw2, Bf*F1, C2*C, C4A*3, C4B*Q0.
HLA typing
Serological typing of HLA-A, -B and -C antigens was carried
out using a standard microcytotoxicity method. HLA-DR spec-
ificities were determined by a standard cytotoxicity test on
enriched B cells, and using Southern analysis of genomic DNA
digested with Taq I restriction enzymes and probed with a DRB
cDNA [16, 24]. HLA class II associations in the Japanese study
group have been reported [11]. In brief, in the Japanese study
population there were significant increases in HLA-DR2: (25/31
patients vs. 21/50 controls; P = 0.006; Pc = 0.06; RR = 5.8);
—DQwl (27/31 vs. 30/50; P 0.007; Pc = 0.03; RR = 10.8); and
—Dw2,DR2 (21/22 vs. 6/21; P = 0.000029; RR = 52.5).
DNA analysis
Genomic DNA was extracted from leukocytes as previously
described [25] and stored at —20°C until use. DNA was digested
with restriction enzymes according to previous methods [16],
and then separated on 0.7% agarose gels, transferred onto nylon
filters (Genescreen plus, DuPont Co., Stevenage, UK) and
hybridized with 32P-labeled cDNA probe as previously de-
scribed [26]. Filters were washed to a high stringency (0.2 X
SSC) and exposed to Kodak X-ray film at —70°C against an
image intensifying screen.
DNA probes
The C4 probe was the 476 bp Barn HI/KpnI fragment of the
full length probe pAT-A (provided by Dr. R.D. Campbell) [27}.
This hybridizes with the 5' ends of both C4A and C4B genes. It
was used to provide information about the presence and size of
C4A and C4B genes. Probes were labelled with alpha-[32p]
dCTP (Amersham International) by random hexanucleotide
priming [28].
Interpretation of Southern blots
RFLP patterns were used to define the C4A and C4B loci as
follows (Figs. 1 and 2): after Taq I digestion, the C4 probe
hybridizes to a 7.0 kb fragment representing the 5' end of the
normal C4A gene. Absence of this fragment and presence of a
unique 6.4 kb fragment has been shown to represent deletion of
C4A [20]. The 5' end of the C4B locus produces a 6.0 ("long"
C4B) or 5.4 ("short" C4B) fragment. Absence of both these
fragments corresponds to homozygous C4B deletion [20].
Scanning densitometry was used to compare the intensities of
C4B and C4A bands in certain cases. The area under the curve
was computed for each fragment. The C4B:C4A ratio was
calculated as the sum of densitometric readings for 6.0 5.4 kb
bands divided by the sum for 7.0 6.4 bands in the same track.
Statistical analysis
All comparisons were analyzed for statistical significance by
the Chi-square method or Fisher's exact test. Where indicated,
P values were multiplied by the total number of antigen
comparisons made at the same HLA locus to give a corrected P
(Pc), according to the method of Svejgaard et al [29].
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MA 21-A C4B long 21-B
Taql I 7.0
C4B short
fusion
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160 I
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Fig. 2. Taq I digests of genomic DNA hybridized with the C4 probe, pAT-A. 7.0 and 6.4 kb fragments represent intact and deleted C4A
respectively; 6.0 and 5.4 kb fragments represent the "long" and "short" forms of C4B respectively. Tracks 1 & 4, from HLA homozygous
individuals WT49 and AVL, respectively; tracks 2 & 3, from healthy Japanese controls.
Results
Analysis of C4A and C4B genes in healthy controls
Representative Southern blots illustrating the four Taq I
RFLP fragments used to describe the C4A and C4B genes are
shown in Figure 2. The HLA homozygous typing cell (WT49) in
track 1 exhibits the normal C4A and the short form of C4B,
represented by 7.0 and 5.4 kb fragments, respectively. The
individual represented in track 4 (AVL) is homozygous for C4A
deletion, shown by a novel 6.4 kb fragment. Track 2 illustrates
a Japanese control who has a normal C4A genotype, and both
the long and short forms of C4B represented by 6.0 and 5.4 kb
fragments, respectively. The healthy Japanese control in track
3 is heterozygous for the normal and deleted C4A genes, and
has the C4B short gene.
IMN in European Caucasoids is associated with C4A gene
deletion
C4A deletion, denoted by the presence of a novel 6.4 Taq I
fragment, was present in 17/27 caucasoid patients (63%) and
13/65 (20%) healthy controls (RR 6.8; P 0.003; Table 1). Five
patients were homozygous for the 6.4 Taq I fragment, giving a
genotypic frequency (for C4A deletion) of 22/54 (4 1%) in
Caucasoid IMN patients. Seventeen Caucasoid patients exhib-
ited the B8, DR3 haplotype, of whom 16 displayed the C4A
deletion genotype. All 10 haplotypes of patients homozygous
for Al, B8, DR3 were also homozygous for the C4A deletion
Table 1. Frequency
Caucasoid patients an
distribution of C4A and C4B genotypes among
d controls revealed by pAT-A probe on Taq I
digests of genomic DNA
Patients Controls
N=27 N=65
Kilobases N % N % P RR
7.0 (C4A normal) 22 81 64 99
6.4 (C4A deleted) 17 63 13 20 0.003 6.8
6.0 (C413 long) 12 44 49 75
5.4 (C4B short) 12 44 39 60
genotype (Fig. 3). Conversely, only one of 17 C4A deletion
genotypes found in Caucasoid patients occurred in a non-B8,
DR3 subject. These data are consistent with strong positive
linkage disequilibrium between C4A deletion and the extended
Al, B8, DR3 haplotype. Definitive proof of linkage awaits
family studies. C4B short is usually on the same haplotype as a
deleted C4A gene [19, 21]. This is the probable explanation for
the observed reduction in the frequency of C4B long in the
patient group compared with controls.
Analysis of C4A deletion in Japanese IMN patients and
healthy controls
The frequencies of C4A gene phenotypes in 30 patients and
46 Japanese controls are shown in Table 2. There was no
7.0
6.4
5.4
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Fig. 3. Taq I digests of genomic DNA from six caucasoidAl B8 DR3 homozygous IMN patients (A, B, D-G) and HLA homozygous controls (H
= QBL, I = AVL, C = West Indian B8 DR3), probed with pAT-A. C4A deletion in A, B, D-G & I is revealed by absence of 7.0 fragment and
presence of a novel 6.4 fragment. C4B deletion in H is shown by absence of 6.0 and 5.4 fragments.
Table 2. Frequency distribution of C4A and C4B genotypes among
Japanese patients and controls revealed by pAT-A probe on Taq 1
digests of genomic DNA
Patients
N=30
Controls
N=46
Kilobases N % N %
7.0 30 100 46 100
6.4 1 3 1 2
6.0 22 73 39 87 NS
5.4 23 77 35 78
a Data on 45 patients available
significant difference in the frequency of C4A deletion between
patients and controls. The overall frequency of the C4A dele-
tion genotype in patients and controls was 2/76 (2.6%). No case
of homozygous C4A deletion was identified, giving an overall
genotypic frequency (for C4A deletion) of 2/152 (1.3%).
Analysis of C4B genes in Japanese patients and controls
The distribution of 6.0 and 5.4 Taq I fragments in 75 subjects
analysed is shown in Table 2. This reveals no significant disease
associations with the C4 RFLPs representing the long and short
forms of C4B. Further, deletion of the C4B gene can be
excluded in 44 subjects with both the long and short genotypes
of C4B, if it is assumed that the long and short genes they
represent are on different chromosomes. The remaining 31
subjects had either a 6.0 fragment or a 5.4 fragment, and
therefore must have at least one intact C4B gene. To assess the
possibility of heterozygous C4B deletion in these subjects, we
examined the intensity of the C4B-associated fragments relative
to the intensity of the C4A-associated fragments. In 20/28 (71%)
subjects assessed, the densitometric ratio suggested there was
an equivalent or slightly greater amount of DNA in C4B-
compared to C4A-fragments, consistent with homozygosity at
the C4B locus. The C4B:C4A ratio was inverted in 8/28 (29%)
subjects examined (4/13 patients and 4/15 controls), suggesting
that these individuals had only a single copy of C4B. Since no
one with homozygous C4B deletion was identified, the overall
genotypic frequency of C4B deletion was estimated at 8/56
haplotypes (14%).
Discussion
The results of this present study show a positive correlation
between C4A gene deletion and susceptibility to idiopathic
membranous nephropathy in British Caucasoids. The presence
of C4A deletion increased the relative risk of IMN by about
sevenfold. This compares to an increased relative risk of four-
to eight-fold conferred by the HLA class II antigen, HLA-DR3,
in Europeans [2—81.
One interpretation of this result is that immune dysfunction
related to heterozygous or homozygous deficiency of C4A
contributes to the pathogenesis of IMN. Congenital deficiency
particularly of the early components of complement predis-
poses to a number of different types of immune complex
glomerulonephritis [30, 31]. The functions of complement in-
clude enhanced clearance of immune complexes by opsoniniza-
tion and solubilization [30]. A plausible explanation for these
current observations, therefore, is that defective clearance of
immune complexes, perhaps associated with an antigen re-
sponse mediated by HLA class II, leads to the evolution of
immune complex glomerulonephritis.
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Alternatively, C4A deletion could have no direct role in the
pathogenesis of IMN, but is increased due to linkage disequi-
librium with another disease susceptibility locus or loci in the
HLA complex. Segregation studies in British Caucasoids have
indicated that almost all of the increase in DR3 associated with
IMN is due to the Al, B8, DR3 haplotype [7, 8, 16]. Our data
are fully consistent with linkage of C4A deletion and Al, B8,
DR3 on the same haplotype, in that there is almost complete
overlap between the possession of the 6.4 Taq I fragment and
the Caucasoid Al, B8, DR3 phenotype. Other candidate dis-
ease-susceptibility genes in the Al, B8, DR3 haplotype, include
other HLA class III loci concerned with immunoregulatory
function, such as tumor necrosis factor or heat shock protein
[32, 33], the HLA class II genes [361, and non-HLA genes in the
class II region involved in processing and presentation of
antigen to regulatory T cells [34, 35].
To distinguish between the possibilities of a primary or
secondary association of C4A deletion with IMN, we analysed
the frequency of C4A deletion in another racial group in which
there is known to be a strong association with HLA markers,
but on a non-DR3 haplotype [11]. A similar trans-racial strategy
has been useful in assessing the contribution of C4A deletion to
the risk of SLE [18, 191. Our results show that there was no
independent association of C4A deletion with IMN in Japanese.
Either this must mean that C4A deletion is irrelevant to the
evolution of IMN, or that Japanese and Caucasoid IMN have
separate genetic mechanisms.
A number of different exogenous factors, such as chronic
infections, drugs and toxins, have been named as causes of
secondary IMN. More than one pathogenetic mechanism may
therefore exist. Moreover, there is marked geographical varia-
tion in the natural history of the disease, in that IMN rarely
leads to end-stage renal failure in Japan, compared to western
countries in which progressive renal disease is reported in
one-half to one-third of patients with IMN. It is also relevant
that no HLA-disease association in Americans has been clearly
established [1, 3]. A different set of genetic and environmental
factors may therefore combine to produce a similar disease in
different parts of the world.
It should be realised that our results do not exclude the
possibility of an association with those C4 null phenotypes
which are due to non-expression rather than deletion of a C4A
gene. Only about 50% of null alleles have been estimated to
arise from actual deletion of the C4A gene [20]. Our examina-
tion will only identify those due to C4A deletion. Studies of
complement protein allotype are clearly needed to address this
issue in Japanese and other study groups.
The results of the current analysis also indicate that C4B
deletion is unlikely to provide an alternative disease association
in Japanese. C4B and C4A have some functional similarities
[23], and C4B null alleles occur in about 7% of the Japanese
population, compared with only 2% for C4A null [37]. How-
ever, we found no increase in the frequency of C4B deletion in
our study population. It can be difficult to assess heterozygous
C4B deletion by measurement of the intensities of bands
revealed by autoradiography. However, we found no difference
between patients and controls in these measurements. More-
over, the frequency of C4B deletion estimated in the present
study was remarkably close to the reported prevalence of C4B
null in the general Japanese population [37].
The C4B short gene has also been found with increased
frequency in patients with SLE from more than one racial group
[19]. This is probably because C4B short is usually present on
the same haplotype as deleted C4A gene [20, 22]. Our data do
not support an independent association of C4B length polymor-
phism with DR2-associated autoimmune disease.
In conclusion, we have shown a significant association be-
tween C4A deletion and risk of IMN in Caucasoids, of similar
proportions to the risk associated with class II markers on the
same haplotype [2—6]. However, we found no significant asso-
ciation between C4 polymorphism, as detected by RFLP, and
risk of IMN in Japanese. This could favor a primary influence of
HLA class II genes on disease susceptibility, and imply that the
association with HLA class III in Caucasoids might be due to
linkage disequilibrium with HLA class II. An alternative expla-
nation which seems also tenable at this point is that more than
one genetic pathway could be involved, which in Caucasoids
might be dependent on C4A and HLA class II genes.
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